In Vitro Evaluation of Faropenem Activity Against Anaerobic Bacteria
Authors:
- L. DubreuilLDL. Dubreuil
- A. BryskierABA. Bryskier
- 1 February 2005
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 17 (1) , 36-45
Abstract
Faropenem, a new oral penem with broad spectrum activity, could be used as empirical treatment in infections due to unidentified anaerobes, but only a few investigations have been carried out on these bacteria. The aim of this study was to compare faropenem in vitro activity with that of positive antimicrobial controls (metronidazole, imipenem, meropenem, amoxicillin, amoxicillin-clavulanic acid, ticarcillin-clavulanic acid, cefotetan, cefoxitin and clindamycin) against 462 anaerobic bacterial strains. The reference agar dilution method was used according to the NCCLS standard. Faropenem demonstrated high antimicrobial activity, similar to that of both imipenem and meropenem (faropenem Minimal Inhibitory Concentrations 50% and 90% were 0.12 and 1 mg/L for all Gram-negative anaerobes, 0.25 and 1 mg/L for all Gram-positive anaerobes). Only 5 strains of the Bacteroides fragilis group (1.1% of all anaerobes) were resistant to faropenem, which compared favorably with that of other reference antianaerobic drugs. The results obtained confirm those previously reported.Keywords
This publication has 26 references indexed in Scilit:
- In VitroStudies on the Impact of Human Serum on the Antibacterial Effect of FaropenemJournal of Chemotherapy, 2004
- Resistance to β-Lactams - The PermutationsJournal of Chemotherapy, 2003
- Pharmacodynamic properties of faropenem demonstrated by studies of time- kill kinetics and postantibiotic effectJournal of Antimicrobial Chemotherapy, 1997
- The in-vitro activity of faropenem, a novel oral penemJournal of Antimicrobial Chemotherapy, 1997
- Comparative in vitro activity of furopenem against aerobic bacteria isolated from pediatric patientsDiagnostic Microbiology and Infectious Disease, 1995
- Evaluation of the in-vitro activity of furopenem (SY5555 or SUN5555) against respiratory tract pathogens and β-lactamase producing bacteriaJournal of Antimicrobial Chemotherapy, 1995
- A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United StatesDiagnostic Microbiology and Infectious Disease, 1994
- A selective medium for Fusobacterium spp.Journal of Applied Bacteriology, 1991
- Evaluation of two methods for rapid testing for beta-lactamase production inBacteroides andFusobacteriumEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anaerobic bacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989